Cornelius Clancy, MD, highlights the real-world outcomes of cefiderocol treatment for serious gram-negative bacterial infections, reporting a clinical success rate of 75% along with encouraging safety data.
Cornelius (Neil) Clancy, MD
Advertisement
Professor of Medicine at the University of Pittsburgh.
Articles by Cornelius (Neil) Clancy, MD
Advertisement
Latest Updated Articles
Real-World Effectiveness of Cefiderocol in Treating Serious Gram-Negative Infections: Insights from the PROVE StudyPublished: October 19th 2024 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
Dynavax and Vaxart Partner to Advance Oral COVID-19 Vaccine
2
Using Doxycycline for Post-Exposure Prevention of Lyme Disease in Young Kids
3
FDA Clears Immuron’s IMM-529 For Clinical Testing in C difficile; Phase 2 Set to Begin in Australia
4
Clesrovimab Lowers RSV Hospitalizations and Illness in Healthy Infants
5
